PL2990031T3 - Pozajelitowa postać norepinefryny - Google Patents
Pozajelitowa postać norepinefrynyInfo
- Publication number
- PL2990031T3 PL2990031T3 PL15182596T PL15182596T PL2990031T3 PL 2990031 T3 PL2990031 T3 PL 2990031T3 PL 15182596 T PL15182596 T PL 15182596T PL 15182596 T PL15182596 T PL 15182596T PL 2990031 T3 PL2990031 T3 PL 2990031T3
- Authority
- PL
- Poland
- Prior art keywords
- norepinephrine
- dosage form
- parenteral dosage
- parenteral
- dosage
- Prior art date
Links
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 title 1
- 229960002748 norepinephrine Drugs 0.000 title 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 title 1
- 239000006201 parenteral dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2759MU2014 | 2014-08-28 | ||
| EP15182596.5A EP2990031B1 (en) | 2014-08-28 | 2015-08-26 | Parenteral dosage form of norepinephrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2990031T3 true PL2990031T3 (pl) | 2020-05-18 |
Family
ID=55401249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15182596T PL2990031T3 (pl) | 2014-08-28 | 2015-08-26 | Pozajelitowa postać norepinefryny |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9877935B2 (pl) |
| EP (1) | EP2990031B1 (pl) |
| JP (1) | JP6812094B2 (pl) |
| ES (1) | ES2770731T3 (pl) |
| PL (1) | PL2990031T3 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190350881A1 (en) | 2016-06-17 | 2019-11-21 | Ys Pharmtech | Stabilization of epinephrine formulations |
| US10835503B2 (en) * | 2017-01-13 | 2020-11-17 | Teva Pharmaceuticals Usa, Inc. | Pre-filled syringe |
| US20250177328A1 (en) | 2017-01-30 | 2025-06-05 | Nevakar Injectables Inc. | Norepinephrine compositions and methods therefor |
| CA3051467C (en) | 2017-01-30 | 2022-11-29 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
| WO2019183416A1 (en) | 2018-03-23 | 2019-09-26 | Nevakar Inc. | Epinephrine compositions and containers |
| SI3659594T1 (sl) * | 2018-11-30 | 2021-02-26 | Klaus Stegemann | Sterilna raztopina z aplikacijskim injektorjem, ki vsebuje medicinsko sredstvo in postopek z proizvodnjo le-te |
| CN109394683A (zh) * | 2018-12-07 | 2019-03-01 | 远大医药（中国）有限公司 | 一种重酒石酸去甲肾上腺素注射液的制备方法 |
| JP7541984B2 (ja) * | 2019-01-10 | 2024-08-29 | サン ファーマシューティカル インダストリーズ リミテッド | エピネフリンの安定な水性注射溶液 |
| WO2020232424A1 (en) | 2019-05-16 | 2020-11-19 | Nexus Pharmaceuticals, Inc. | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
| CN114286669A (zh) * | 2019-08-08 | 2022-04-05 | 太阳医药工业有限公司 | 去甲肾上腺素的输注剂型 |
| CA3174640A1 (en) * | 2020-03-06 | 2021-09-10 | Baxter International Inc. | Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation |
| JP2022530581A (ja) * | 2020-04-03 | 2022-06-30 | ファルコ－ファルマ ゲーエムベーハー | オキシブチニン含有組成物で満たされた注射器、その注射器の製造方法およびその注射器を含むキット |
| DE102020111080A1 (de) * | 2020-04-03 | 2021-10-07 | Farco-Pharma Gmbh | Spritze und Kit für die intravesikale Anwendung |
| WO2021262677A1 (en) * | 2020-06-24 | 2021-12-30 | Nevakar Injectables Inc. | Methods for reducing catecholamine-formaldehyde adducts |
| PL4051251T3 (pl) | 2020-10-21 | 2024-04-08 | Sintetica S.A. | Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania |
| US20220117843A1 (en) * | 2020-10-21 | 2022-04-21 | Sintetica S.A. | Ready to use, noradrenaline drip bags, having low subvisible particle counts |
| US11331266B1 (en) | 2020-10-29 | 2022-05-17 | Medefil, Inc. | Antioxidant free, norepinephrine bitartrate injection in amber glass vials |
| US20220233473A1 (en) * | 2021-01-28 | 2022-07-28 | Cumberland Pharmaceuticals Inc. | Injectable solution of norepinephrine |
| AR124867A1 (es) | 2021-02-15 | 2023-05-10 | Sintetica S A | Un medicamento en una bolsa de goteo intravenoso plegable lista para usar herméticamente sellada, método para hacer dicho medicamento y medicamento elaborado mediante dicho método |
| CN117357469B (zh) * | 2022-06-29 | 2024-09-10 | 南京臣功制药股份有限公司 | 一种盐酸肾上腺素注射液及其制备方法 |
| US20260021060A1 (en) * | 2022-07-25 | 2026-01-22 | Hikma Pharmaceuticals Usa Inc. | Ready-to-administer product comprising a norepinephrine formulation |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679804A (en) * | 1969-05-01 | 1972-07-25 | Geigy Chem Corp | Method for treating glaucoma with alkyl gallates |
| FR2779061B1 (fr) | 1998-04-14 | 2004-08-20 | Pharmatop | Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant |
| US7243689B2 (en) | 2000-02-11 | 2007-07-17 | Medical Instill Technologies, Inc. | Device with needle penetrable and laser resealable portion and related method |
| JP2004509920A (ja) * | 2000-09-29 | 2004-04-02 | ボード オブ トラスティーズ オペレーティング ミシガン ステート ユニヴァーシティ | カテコールアミン医薬組成物および方法 |
| FR2832063B1 (fr) | 2001-11-15 | 2004-08-27 | Aguettant Lab | Procede de production de solutions stables de substances phenoliques et les solutions en resultant |
| EP2546152A3 (en) | 2002-09-03 | 2014-03-26 | Medical Instill Technologies, Inc. | Sealed containers and methods of making and filling same |
| CN1634123A (zh) * | 2004-10-15 | 2005-07-06 | 凌沛学 | 含卵磷脂和玻璃酸钠的眼科给药系统及其制备方法 |
| DE102004063764A1 (de) * | 2004-12-29 | 2006-07-13 | Hexal Ag | Kunststoff-Flasche für Oxaliplatin |
| US8367734B1 (en) | 2005-08-11 | 2013-02-05 | Amphastar Pharmaceuticals Inc. | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| WO2010017653A1 (zh) * | 2008-08-11 | 2010-02-18 | 中国人民解放军第三军医大学药学院 | 抗心肌重构多肽、其制备方法、制剂及在制备抗心肌重构药物中的应用 |
| AU2015202494B2 (en) | 2008-12-30 | 2015-12-10 | Xvivo Perfusion Ab | A composition comprising nor-adrenaline and a NET inhibitor for administering to a brain-dead, heart-beating potential organ donor |
| US8628805B2 (en) * | 2009-06-04 | 2014-01-14 | Alk Ag | Stabilized composition comprising at least one adrenergic compound |
| CN102802668A (zh) * | 2009-06-04 | 2012-11-28 | Alk股份公司 | 包含至少一种肾上腺素能化合物的稳定化组合物 |
| US20140343159A1 (en) | 2011-06-02 | 2014-11-20 | Procertus Biopharm, Inc. | Formulation of small adrenergic agonist salt forms in organic solvents |
| RU2015100517A (ru) | 2012-06-13 | 2016-08-10 | ДР. ПИ ИНСТИТЬЮТ ЭлЭлСи | Устройство, имеющее протыкаемую перегородку, заполняющую иглу и протыкаемую крышку, и связанный с ним способ |
| UY35988A (es) | 2014-02-27 | 2015-09-30 | Sint Sa | Proceso para la producción de una solución inyectable de noradrenalina de baja concentración |
-
2015
- 2015-08-26 PL PL15182596T patent/PL2990031T3/pl unknown
- 2015-08-26 ES ES15182596T patent/ES2770731T3/es active Active
- 2015-08-26 EP EP15182596.5A patent/EP2990031B1/en active Active
- 2015-08-27 US US14/837,749 patent/US9877935B2/en active Active
- 2015-08-27 JP JP2015167928A patent/JP6812094B2/ja active Active
-
2018
- 2018-01-19 US US15/875,475 patent/US11166923B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6812094B2 (ja) | 2021-01-13 |
| US20160058715A1 (en) | 2016-03-03 |
| US11166923B2 (en) | 2021-11-09 |
| EP2990031B1 (en) | 2019-11-13 |
| JP2016050205A (ja) | 2016-04-11 |
| US9877935B2 (en) | 2018-01-30 |
| EP2990031A1 (en) | 2016-03-02 |
| ES2770731T3 (es) | 2020-07-02 |
| US20180140563A1 (en) | 2018-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2990031T3 (pl) | Pozajelitowa postać norepinefryny | |
| IL270954A (en) | Pharmaceutical compounds | |
| GB201419579D0 (en) | Pharmaceutical compound | |
| GB201414730D0 (en) | Pharmaceutical compound | |
| PL3287124T3 (pl) | Doustna postać dawkowania ketaminy | |
| GB201404922D0 (en) | Pharmaceutical compounds | |
| PL3484451T3 (pl) | Postać dawkowana | |
| GB201416513D0 (en) | Pharmaceutical compounds | |
| GB201417707D0 (en) | Pharmaceutical compounds | |
| HUS2500045I1 (hu) | Etilén-glikolok MMF származékai | |
| GB201416788D0 (en) | Therapeutic applications for pyocins | |
| GB201407822D0 (en) | Use of a composition | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| IL249374A0 (en) | Pharmaceutical administration forms | |
| GB201408735D0 (en) | Application coordination | |
| ZA201507042B (en) | Parenteral dosage form of amiodarone | |
| TWM490349U (en) | Improved structure of a darter | |
| GB201415811D0 (en) | Solid dosage form production | |
| GB201508022D0 (en) | Pharmaceutical compounds | |
| GB201417192D0 (en) | Deposition of graphene | |
| GB201419570D0 (en) | Pharmaceutical compound | |
| GB201416968D0 (en) | Pharmaceutical compounds | |
| GB201416969D0 (en) | Pharmaceutical compounds | |
| GB201416627D0 (en) | Pharmaceutical compounds | |
| GB201416622D0 (en) | Pharmaceutical compounds |